Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 1.097
Filter
1.
Hepatology ; 80(3): 501-502, 2024 Sep 01.
Article in English | MEDLINE | ID: mdl-39166819
8.
J Gastroenterol Hepatol ; 39(8): 1528-1534, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38634347

ABSTRACT

BACKGROUND AND AIM: Rapidly aging societies have become a major issue worldwide including Japan. This study aimed to elucidate relative changes in the characteristics of inpatients in Japan related to this issue. METHODS: A total of 23 835 Japanese inpatients treated from 2010 to 2021 were enrolled (2010-2013, period I; 2014-2017, period II; 2018-2021, period III). Changes in clinical features were retrospectively analyzed based on ICD-10 diagnosis data. RESULTS: The percentage of patients aged over 75 years increased over time (period I, 38.0%; II, 39.5%, III, 41.4%). Emergency admissions comprised 27.5% of all in period I, which increased to 43.2% in period II and again to 44.5% in period III (P < 0.001). In period I, gastrointestinal disease, liver disease, pancreatic-biliary disease, and other disease types were noted in 47.4%, 29.5%, 19.2%, and 3.9%, respectively, while those values were 44.0%, 18.0%, 33.9%, and 4.1%, respectively, in period III (P < 0.001). The frequency of liver disease decreased by approximately 0.6-fold from periods I to III, while that of biliary-pancreatic disease increased by approximately 1.8-fold during that time. Both percentage and actual numbers of patients with biliary-pancreatic disease increased during the examined periods. Analysis of changes in the proportion of organs affected by malignancy during periods I, II, and III showed a marked increase in cases of biliary-pancreatic malignancy (11.6%, 19.5%, 26.6%, respectively) (P < 0.001). CONCLUSION: In association with the rapidly aging Japanese society, there has been an increasing frequency of biliary-pancreatic disease cases requiring hospitalization for treatment in the west Japan region of Shikoku.


Subject(s)
Gastroenterology , Inpatients , Humans , Japan/epidemiology , Aged , Retrospective Studies , Male , Inpatients/statistics & numerical data , Female , Gastroenterology/statistics & numerical data , Gastroenterology/trends , Aged, 80 and over , Middle Aged , Aging , Liver Diseases/epidemiology , Liver Diseases/therapy , Liver Diseases/diagnosis , Biliary Tract Diseases/epidemiology , Biliary Tract Diseases/therapy , Gastrointestinal Diseases/epidemiology , Gastrointestinal Diseases/therapy , Gastrointestinal Diseases/diagnosis , Hospitalization/statistics & numerical data , Time Factors , Age Factors , Adult , Pancreatic Diseases/epidemiology , Pancreatic Diseases/therapy
9.
Nat Rev Gastroenterol Hepatol ; 21(5): 299, 2024 May.
Article in English | MEDLINE | ID: mdl-38480848
12.
Rev. esp. enferm. dig ; 115(5): 248-258, 2023. tab
Article in Spanish | IBECS | ID: ibc-220284

ABSTRACT

La medicina y la tecnología están en continua evolución. La pandemia ha acelerado el desarrollo de la digitalización del sector sanitario y, en concreto, de la telemedicina. Mediante una revisión bibliográfica estructurada siguiendo la metodología Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA), en este trabajo se definen los conceptos relacionados con la telemedicina, su aplicación y el contexto regulatorio legal. Con esta información, se proponen unas recomendaciones y códigos de buenas prácticas para su implementación efectiva en el ámbito de la Hepatología (AU)


Subject(s)
Humans , Gastroenterology/trends , Telemedicine/trends , Remote Consultation/trends
13.
Dig Dis Sci ; 67(2): 390-396, 2022 02.
Article in English | MEDLINE | ID: mdl-35094252

ABSTRACT

BACKGROUND: Over the last few decades, advances have been made regarding gender equality starting from medical students to trainees, to leadership in academics. The female representation in specialty academic conferences not only reflects the existing gender disparities in that specialty but also can influence young female trainees to join that field. Digestive Disease Week (DDW) is the premier digestive disease event. We aimed to calculate the proportion of female representation among speakers and moderators at the DDW meetings held from 2018 to 2020. METHODS: The data for DDW 2018-2020 were collected via the online web-based planner. The gender of speakers of presentations and moderators of sessions were identified by a google search. We further categorized the data by each participating society (AGA, ASGE, AASLD, and SSAT), by presentation track, by session track, and total overall representation in each year. RESULTS: Despite the subject of the gender gap being in focus, the proportion of female moderators and speakers was low in DDW in the last 3 years. The female speakers constituted 31.6% in 2018, 33.8% in 2019 and 34.6% in 2020. There was slightly improved female representation in sessions of Inflammatory Bowel Disease, Stomach, and Small Bowel Disorders, Microbiome in GI & Liver disease, and Basic Science over the last 3 years. CONCLUSION: Based on our study and those referenced in this article, we believe that strategies to promote the inclusivity of female moderators and speakers at DDW provide a huge opportunity to influence gender equity within GI.


Subject(s)
Congresses as Topic/trends , Gastroenterology/trends , Physicians, Women/trends , Digestive System Diseases , Humans , Societies, Medical
14.
Hepatology ; 75(3): 724-739, 2022 03.
Article in English | MEDLINE | ID: mdl-35028960

ABSTRACT

The rise in innovative digital health technologies has led a paradigm shift in health care toward personalized, patient-centric medicine that is reaching beyond traditional brick-and-mortar facilities into patients' homes and everyday lives. Digital solutions can monitor and detect early changes in physiological data, predict disease progression and health-related outcomes based on individual risk factors, and manage disease intervention with a range of accessible telemedicine and mobile health options. In this review, we discuss the unique transformation underway in the care of patients with liver disease, specifically examining the digital transformation of diagnostics, prediction and clinical decision-making, and management. Additionally, we discuss the general considerations needed to confirm validity and oversight of new technologies, usability and acceptability of digital solutions, and equity and inclusivity of vulnerable populations.


Subject(s)
Biomedical Technology , Gastroenterology , Patient Care Management , Biomedical Technology/methods , Biomedical Technology/trends , Computing Methodologies , Gastroenterology/methods , Gastroenterology/trends , Humans , Inventions , Patient Care Management/methods , Patient Care Management/trends
15.
Gastroenterol. latinoam ; 33(1): 35-42, 2022. tab
Article in Spanish | LILACS | ID: biblio-1524113

ABSTRACT

Google Trends (GT) is an online portal that provides data on user search patterns. It is currently widely used in the vast majority of medical specialties. Objective: to analyze publications in gastroenterology that have used GT as an epidemiological tool. Methods: Using PubMed, Lilacs, Google Schoolar Academic and Scopus, we searched for gastroenterology articles that contained GT in their title or abstract between the years 2011 to 2021. Titles/abstracts had to also include at least one out of 49 terms related to digestive diseases from symptoms to treatments. Results: The 30 articles selected addressed topics such as symptoms, different pathologies including infectious, diagnostic methods and diets, among others. Conclusions: GT is a very useful tool to measure what people search for on the Internet and allows us to detect epidemic outbreaks, evaluate the impact of the days dedicated to some pathology as well as the impact of publications on the network of the public and doctors.


Google Trends (GT) es un portal en línea que proporciona datos sobre patrones de búsqueda de los usuarios. Actualmente muy utilizado en la gran mayoría de las especialidades médicas. Objetivo: analizar las publicaciones en gastroenterología que han usado a GT como herramienta epidemiológica. Material y Método: Mediante PubMed, Lilacs, Google Schoolar Academic y Scopus buscamos los artículos de gastroenterología que contenían a GT en su título o en el resumen entre los años 2011 a 2021. Los títulos/resúmenes debían incluir además, al menos uno de 49 términos relacionados a enfermedades digestivas desde síntomas hasta tratamientos. Resultados: Los 30 artículos seleccionados abordan temas como síntomas, distintas patologías incluyendo infecciosas, métodos diagnósticos y dietas, entre otras. Conclusiones: GT es una herramienta de gran utilidad para medir lo que las personas buscan en internet y permite detectar brotes epidémicos, evaluar el impacto de los días dedicados a de alguna patología así como el impacto de publicaciones en la red del público y médicos.


Subject(s)
Humans , Search Engine , Gastroenterology/trends
16.
Am J Gastroenterol ; 116(10): 1969, 2021 10 01.
Article in English | MEDLINE | ID: mdl-34618694
18.
Hepatol Commun ; 5(11): 1810-1823, 2021 11.
Article in English | MEDLINE | ID: mdl-34499435

ABSTRACT

Nonalcoholic steatohepatitis (NASH) can progress to cirrhosis and its complications, including hepatocellular carcinoma. Given that the majority of patients with NASH are asymptomatic, developing screening strategies to identify those individuals at risk for progressive NASH remains a highly unmet need. Furthermore, noninvasive tests that accurately predict disease progression as part of the natural history of NASH or regression in response to treatment are urgently needed to decrease the reliance on repeat liver biopsies. To date, there are no US Food and Drug Administration (FDA)-approved medications for NASH that can resolve steatohepatitis and lead to fibrosis regression. The lack of FDA-approved therapy has led to apathy in diagnosis and referral for specialty care. However, several therapeutic agents are rapidly progressing through the different phases of clinical trials with several already in phase 3 programs. In this review, we provide a summary of recent developments in NASH diagnostics and therapeutics that are likely to shape the future management of this underdiagnosed and undertreated disease.


Subject(s)
Gastroenterology/trends , Mass Screening/trends , Non-alcoholic Fatty Liver Disease/diagnosis , Non-alcoholic Fatty Liver Disease/therapy , Forecasting , Humans
SELECTION OF CITATIONS
SEARCH DETAIL